Healthcare & Pharmaceuticals Industry Press Releases

Published on October 4, 2023 - 12:30 GMT

Kineta Presents New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and ...

SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the presentation of new …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on October 4, 2023 - 12:30 GMT

BrightInsight to Showcase Key Updates to its BrightInsight Platform and Disease Management Solution at HLTH 2023

SAN JOSE, Calif. and LAS VEGAS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech digital health solutions, announced today that it will showcase the latest technical enhancements to …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on October 4, 2023 - 12:30 GMT

Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine

ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 12:30 GMT

Sienna Announces Third Quarter 2023 Results Release Date and Conference Call

MARKHAM, Ontario, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2023 third quarter results after market close on Thursday, November 9, 2023. Nitin Jain, President and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 12:30 GMT

Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss ...

SOLANA BEACH, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 12:30 GMT

Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy

BOSTON and ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 12:30 GMT

Veru Reports Muscle Data from 5 Clinical Studies of Enobosarm that Support the Advancement of Enobosarm in Combination with Weight-...

-- In 5 clinical studies involving 968 older men and postmenopausal women with and without muscle wasting, enobosarm has demonstrated the ability to decrease fat mass, increase muscle mass, and improve muscle strength and physical function -- -- Weight- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 12:30 GMT

Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity

SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today disclosed the submission of a Patent Cooperation Treaty (PCT) …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...

Published on October 4, 2023 - 12:05 GMT

Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy ...

Spero is another addition to the growing Superlatus CPG portfolio under their Urgent Company umbrella of brands. Spero® is a plant-based tech company specializing in alternative dairy and egg replacements, on a mission to outcompete traditional dairy and …

Distribution channels:

Published on October 4, 2023 - 12:01 GMT

Ocean Biomedical Announces Loan Commitment from Largest Stockholder; Up to $10 Million

Providence, RI, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today that it has entered into a non-binding term sheet with its largest stockholder, Poseidon Bio, LLC, majority owned by Dr. Chirinjeev Kathuria, for a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...